Aptimmune Biologics' Unattributed Round

Aptimmune Biologics raised a round of funding on July 11, 2017.

Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine. The company's current focus is bringing into the market effective prophylax…

Articles about Aptimmune Biologics' Unattributed Round: